DK1601697T3 - Oprensning af antistof ved protein A- og ionbytningskromatografi - Google Patents

Oprensning af antistof ved protein A- og ionbytningskromatografi

Info

Publication number
DK1601697T3
DK1601697T3 DK04715906T DK04715906T DK1601697T3 DK 1601697 T3 DK1601697 T3 DK 1601697T3 DK 04715906 T DK04715906 T DK 04715906T DK 04715906 T DK04715906 T DK 04715906T DK 1601697 T3 DK1601697 T3 DK 1601697T3
Authority
DK
Denmark
Prior art keywords
antibody
purification
protein
ion exchange
exchange chromatography
Prior art date
Application number
DK04715906T
Other languages
English (en)
Inventor
Julian Bonnerjea
Anna Preneta
Original Assignee
Lonza Biologics Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32929391&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1601697(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB0304576.2A external-priority patent/GB0304576D0/en
Application filed by Lonza Biologics Plc filed Critical Lonza Biologics Plc
Application granted granted Critical
Publication of DK1601697T3 publication Critical patent/DK1601697T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction
    • B01D15/361—Ion-exchange
    • B01D15/362—Cation-exchange
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction
    • B01D15/361—Ion-exchange
    • B01D15/363—Anion-exchange
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
    • B01D15/3804—Affinity chromatography
    • B01D15/3809—Affinity chromatography of the antigen-antibody type, e.g. protein A, G, L chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
DK04715906T 2003-02-28 2004-03-01 Oprensning af antistof ved protein A- og ionbytningskromatografi DK1601697T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0304576.2A GB0304576D0 (en) 2003-02-28 2003-02-28 Protein a chromatography
US46497303P 2003-04-24 2003-04-24
PCT/EP2004/002041 WO2004076485A1 (en) 2003-02-28 2004-03-01 Antibody purification by protein a and ion exchange chromatography

Publications (1)

Publication Number Publication Date
DK1601697T3 true DK1601697T3 (da) 2007-10-01

Family

ID=32929391

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04715906T DK1601697T3 (da) 2003-02-28 2004-03-01 Oprensning af antistof ved protein A- og ionbytningskromatografi

Country Status (6)

Country Link
EP (1) EP1601697B1 (da)
AU (1) AU2004215653B2 (da)
CA (1) CA2516518A1 (da)
DK (1) DK1601697T3 (da)
PT (1) PT1601697E (da)
WO (1) WO2004076485A1 (da)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004215653B2 (en) 2003-02-28 2011-03-17 Lonza Biologics Plc. Antibody purification by protein A and ion exchange chromatography
GB0304576D0 (en) 2003-02-28 2003-04-02 Lonza Biologics Plc Protein a chromatography
AU2004265253B2 (en) 2003-07-28 2011-09-01 Genentech, Inc. Reducing protein A leaching during protein A affinity chromatography
WO2005037869A2 (en) * 2003-10-15 2005-04-28 Applera Corporation Method of reducing leachate from protein a affinity media
BRPI0415887B1 (pt) 2003-10-27 2021-01-26 Wyeth métodos para a remoção de agregados de elevado peso molecular utilizando cromatografia de hidroxiapatita
SE0400501D0 (sv) 2004-02-27 2004-02-27 Amersham Biosciences Ab Antibody purification
SE0402558D0 (sv) * 2004-10-21 2004-10-21 Amersham Biosciences Ab A process for the purification of antibodies
EP1685161A1 (en) * 2004-08-30 2006-08-02 Lonza Biologics plc Affinity- plus ion exchange-chromatography for purifying antibodies
BRPI0518216C8 (pt) * 2004-10-21 2017-03-21 Ge Healthcare Bio Sciences Ab ligante de cromatografia, métodos de preparação de uma matriz de separação, e de separação de um ou mais anticorpos de um ou mais outros compostos em uma amostra líquida, matriz de separação, e, coluna de cromatografia descartável.
TW200714290A (en) * 2005-03-08 2007-04-16 Pharmacia & Upjohn Co Llc Anti-M-CSF antibody compositions having reduced levels of endotoxin
CN1830495B (zh) * 2005-03-11 2010-12-15 广东天普生化医药股份有限公司 基于亲和吸附的血液净化方法及系统
ES2797480T3 (es) 2005-03-11 2020-12-02 Wyeth Llc Un procedimiento de cromatografía de reparto débil
TWI320788B (en) 2005-05-25 2010-02-21 Hoffmann La Roche Method for the purification of antibodies
AU2006259298B2 (en) 2005-06-17 2012-06-14 Wyeth Llc Methods of purifying Fc region containing proteins
GB2430883B (en) 2005-09-30 2008-03-19 Cambridge Antibody Tech Interleukin-13 antibody composition
JP2009532474A (ja) 2006-04-05 2009-09-10 アボツト・バイオテクノロジー・リミテツド 抗体精製
SI2061803T2 (sl) * 2006-08-28 2023-01-31 Ares Trading S.A. Postopek za čiščenje proteinov, ki vsebujejo FC
WO2008033517A2 (en) 2006-09-13 2008-03-20 Abbott Laboratories Cell culture improvements
AU2008256411B2 (en) 2007-06-01 2013-08-22 F. Hoffmann-La Roche Ag Immunoglobulin purification
PL2708558T3 (pl) 2008-04-11 2018-09-28 Chugai Seiyaku Kabushiki Kaisha Cząsteczka wiążąca antygen zdolna do wiązania dwóch lub więcej cząsteczek antygenu w sposób powtarzalny
CN103396480A (zh) * 2008-05-15 2013-11-20 诺沃—诺迪斯克有限公司 抗体纯化方法
US8592555B2 (en) 2008-08-11 2013-11-26 Emd Millipore Corporation Immunoglobulin-binding proteins with improved specificity
TWI440469B (zh) 2008-09-26 2014-06-11 Chugai Pharmaceutical Co Ltd Improved antibody molecules
US8058407B2 (en) 2008-10-31 2011-11-15 Wyeth Llc Purification of acidic proteins using ceramic hydroxyapatite chromatography
US8497358B2 (en) 2008-12-19 2013-07-30 Takeda Pharmaceutical Company Limited Antibody purification method
CA2745707A1 (en) 2008-12-22 2010-07-01 F. Hoffmann-La Roche Ag Immunoglobulin purification
SG162687A1 (en) 2008-12-24 2010-07-29 Millipore Corp Caustic stable chromatography ligands
KR101224468B1 (ko) 2009-05-20 2013-01-23 주식회사 파멥신 신규한 형태의 이중표적항체 및 그 용도
MX341136B (es) 2009-10-20 2016-08-09 Abbvie Inc Aislamiento y purificacion de los anticuerpos anti-il-13 al usar la cromatografia de afinidad con proteina a.
US8277649B2 (en) 2009-12-14 2012-10-02 General Electric Company Membranes and associated methods for purification of antibodies
PL2513134T3 (pl) 2009-12-18 2018-02-28 Novartis Ag Roztwór do przemywania i sposób chromatografii powinowactwa
EP2695889A1 (en) 2009-12-29 2014-02-12 Dr. Reddy's Laboratories Limited Protein purification by ion exchange
EP2647706B1 (en) 2010-11-30 2023-05-17 Chugai Seiyaku Kabushiki Kaisha Antigen-binding molecule capable of binding to plurality of antigen molecules repeatedly
CA2820095C (en) 2010-12-21 2019-02-26 F. Hoffmann-La Roche Ag Isoform enriched antibody preparation and method for obtaining it
SG192945A1 (en) 2011-02-25 2013-09-30 Chugai Pharmaceutical Co Ltd Fcgriib-specific fc antibody
US9062106B2 (en) 2011-04-27 2015-06-23 Abbvie Inc. Methods for controlling the galactosylation profile of recombinantly-expressed proteins
SG10201604554WA (en) 2011-06-08 2016-07-28 Emd Millipore Corp Chromatography matrices including novel staphylococcus aureus protein a based ligands
WO2013028330A2 (en) 2011-08-19 2013-02-28 Emd Millipore Corporation Methods of reducing level of one of more impurities in a sample during protein purification
EP2762493B1 (en) 2011-09-30 2021-06-09 Chugai Seiyaku Kabushiki Kaisha Antigen-binding molecule promoting disappearance of antigens having plurality of biological activities
TW201817744A (zh) 2011-09-30 2018-05-16 日商中外製藥股份有限公司 具有促進抗原清除之ＦｃＲｎ結合域的治療性抗原結合分子
SG11201402485UA (en) * 2011-11-21 2014-06-27 Genentech Inc Purification of anti-c-met antibodies
WO2013158273A1 (en) 2012-04-20 2013-10-24 Abbvie Inc. Methods to modulate c-terminal lysine variant distribution
US9067990B2 (en) 2013-03-14 2015-06-30 Abbvie, Inc. Protein purification using displacement chromatography
WO2013158279A1 (en) 2012-04-20 2013-10-24 Abbvie Inc. Protein purification methods to reduce acidic species
US9512214B2 (en) 2012-09-02 2016-12-06 Abbvie, Inc. Methods to control protein heterogeneity
JP2015537212A (ja) * 2012-11-15 2015-12-24 ジェネンテック， インコーポレイテッド イオン強度媒介のｐｈ勾配イオン交換クロマトグラフィー
SG11201507230PA (en) 2013-03-12 2015-10-29 Abbvie Inc Human antibodies that bind human tnf-alpha and methods of preparing the same
US9499614B2 (en) 2013-03-14 2016-11-22 Abbvie Inc. Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosaccharides
US9017687B1 (en) 2013-10-18 2015-04-28 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same using displacement chromatography
WO2014170867A1 (en) 2013-04-18 2014-10-23 Institut National De La Sante Et De La Recherche Medicale Composition with reduced immunogenicity
US9598667B2 (en) 2013-10-04 2017-03-21 Abbvie Inc. Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
US9181337B2 (en) 2013-10-18 2015-11-10 Abbvie, Inc. Modulated lysine variant species compositions and methods for producing and using the same
US9085618B2 (en) 2013-10-18 2015-07-21 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same
US20150139988A1 (en) 2013-11-15 2015-05-21 Abbvie, Inc. Glycoengineered binding protein compositions
HUE048782T2 (hu) 2014-03-10 2020-08-28 Richter Gedeon Nyrt Immunoglobulin tisztítása elõtisztítási lépések alkalmazásával
WO2015189832A1 (en) 2014-06-13 2015-12-17 Lupin Limited Process for the purification of tnfr:fc fusion protein
EA201790558A1 (ru) 2014-10-15 2017-08-31 Ксенотера Композиция с пониженной иммуногенностью
CN107108726A (zh) 2014-12-19 2017-08-29 中外制药株式会社 抗‑肌肉生长抑制因子抗体、包含变体fc区的多肽及使用方法
CN107207607B (zh) 2014-12-19 2021-05-04 中外制药株式会社 抗-c5抗体及使用方法
WO2016103139A1 (en) * 2014-12-22 2016-06-30 Dr. Reddy's Laboratories Method for reduction of aggregates
EP3816179A3 (en) 2015-02-05 2021-08-04 Chugai Seiyaku Kabushiki Kaisha Fc region variant comprising a modified fcrn-binding domain
TWI805046B (zh) 2015-02-27 2023-06-11 日商中外製藥股份有限公司 Il-6受體抗體用於製備醫藥組成物的用途
WO2017110981A1 (en) 2015-12-25 2017-06-29 Chugai Seiyaku Kabushiki Kaisha Anti-myostatin antibodies and methods of use
TW202300168A (zh) 2016-08-05 2023-01-01 日商中外製藥股份有限公司 Il-8相關疾病之治療用或預防用組成物
WO2018139623A1 (en) 2017-01-30 2018-08-02 Chugai Seiyaku Kabushiki Kaisha Anti-sclerostin antibodies and methods of use
US11851486B2 (en) 2017-05-02 2023-12-26 National Center Of Neurology And Psychiatry Method for predicting and evaluating therapeutic effect in diseases related to IL-6 and neutrophils
AU2020266993A1 (en) 2019-04-30 2022-01-06 Xenothera Association of polyclonal antibodies and anti-PD1 or anti-PDL1 antibodies for the treatment of cancer
WO2023012321A1 (en) 2021-08-06 2023-02-09 Roche Diagnostics Gmbh Chimeric igg-fc-binding ligand polypeptide and uses thereof for igg affinity purification

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5084559A (en) * 1987-03-27 1992-01-28 Repligen Corporation Protein a domain mutants
US4983722A (en) * 1988-06-08 1991-01-08 Miles Inc. Removal of protein A from antibody preparations
JPH07155194A (ja) * 1993-12-10 1995-06-20 Teijin Ltd タンパク質の精製法
US5429746A (en) * 1994-02-22 1995-07-04 Smith Kline Beecham Corporation Antibody purification
SE9503925D0 (sv) * 1995-11-07 1995-11-07 Pharmacia Biotech Ab Separationsmedium för IgG
AU2004215653B2 (en) 2003-02-28 2011-03-17 Lonza Biologics Plc. Antibody purification by protein A and ion exchange chromatography

Also Published As

Publication number Publication date
WO2004076485A1 (en) 2004-09-10
AU2004215653A1 (en) 2004-09-10
AU2004215653B2 (en) 2011-03-17
EP1601697B1 (en) 2007-05-30
CA2516518A1 (en) 2004-09-10
PT1601697E (pt) 2007-09-04
EP1601697A1 (en) 2005-12-07

Similar Documents

Publication Publication Date Title
DK1601697T3 (da) Oprensning af antistof ved protein A- og ionbytningskromatografi
DK3095793T3 (da) Reducering af udvaskning af protein A under en protein A-affinitetskromatografi
DK1737971T3 (da) Blandinger af bindingsproteiner
DK1615955T3 (da) Ændring af FCRN-bindingsaffiniteter eller serumhalveringstider af antistoffer ved mutagenese
DK1543038T4 (da) Proteinoprensning
DK1406656T3 (da) Fremgangsmåder til administrering af anti-TNF-alfa-antistoffer
ECSP066436A (es) Compuestos heterociclicos fusionados
DK1599504T3 (da) Modificeret antistof
DE60222658D1 (de) Monoklonaler anti-cd-40-antikörper
DK1800693T3 (da) Adjuvans-terapi ved anvendelse af anti-glypican 3 antistoffer
DK1501856T3 (da) Anti-HER2 antistofvarianter
DK1360169T3 (da) Succinatsalt af O-desmethyl-venlafaxin
NO20044347L (no) Anti-alfavbeta6-antistoff
DK1545574T3 (da) Fremgangsmåde til rensning af polypeptider ved simuleret moving-bed-chromatografi
DE602004026768D1 (de) Therapeutische anti-igfr1-antikörper-kombinationen
DK1647529T3 (da) Fremgangsmåde til oprensing af spildevand
DK1587542T3 (da) Anvendelse af anti-CD100-antistoffer
DK1273592T3 (da) Fremgangsmåde til oprensning af interferonproteiner ved hjælp af kationbytningskromatografi
ATE500256T1 (de) Neue kondensierte pyrrolocarbazole
DK1740534T3 (da) Fremgangsmåde til rensning af mesotrion
DE60220587D1 (de) Ionenaustauschermembran
EE200300569A (et) CD44v6-spetsiifilised antikehad
DK1527690T3 (da) Fremgangsmåde til dearomatisering af valleprotein
DK1377544T3 (da) Oprensning af 2-nitro-4-methylsulfonylbenzoesyre
DK1572613T3 (da) Fremgangsmåde til fremstilling af benzophenoner